NCT07577973

Brief Summary

This randomized controlled trial examines the effects of nurse-led self-acupressure at HT7, LI4, PC6, and EX3 points on blood pressure, stress, and well-being in adults with primary hypertension. Participants are randomized to real acupressure, sham acupressure, or usual care groups for 2 weeks.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
4mo left

Started Jun 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 5, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 11, 2026

Completed
21 days until next milestone

Study Start

First participant enrolled

June 1, 2026

Expected
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Last Updated

May 14, 2026

Status Verified

May 1, 2026

Enrollment Period

3 months

First QC Date

May 5, 2026

Last Update Submit

May 12, 2026

Conditions

Keywords

Acupressure Hypertension Self-care Nursing Stress Well-being Randomized Controlled Trial

Outcome Measures

Primary Outcomes (1)

  • change in blood pressure

    change from baseline in systolic and diastolic blood pressure measured using an automated office blood pressure monitor at 2 weeks

    baseline and week 2

Secondary Outcomes (2)

  • change in perceived stress

    baseline, week 2

  • change in mental well-being

    baseline, week 2

Study Arms (3)

Real Acupressure Group

EXPERIMENTAL

participants receive acupressure on bilateral HT7,LI4,PC6 EX3 points. pressure applied for 15 seconds per point, 3 days per week, for 2 weeks

Behavioral: Real Acupressure

sham/placebo

SHAM COMPARATOR

Participants receive sham acupressure on non-acupoints located 1-1.5 cm away from HT7, LI4 , PC6, and EX3 points. Pressure applied for 15 seconds per site, 3 days per week, for 2 weeks to maintain participant blinding

Behavioral: sham acupressure

control

ACTIVE COMPARATOR

Participants receive usual care for hypertension including prescribed antihypertensive medications and routine clinical nursing follow-up for 2 weeks. No acupressure intervention applied.

Other: Usual Care

Interventions

Acupressure applied to HT7 (Shenmen), LI4 (Hegu), PC6 (Neiguan) bilaterally, and EX3 (Yintang). Pressure applied for 15 seconds per point, 3 days per week for 2 weeks by trained researcher. Total session duration approximately 1 minute.

Real Acupressure Group

light pressure applied to non-acupoint sites 1-1.5 cm from HT7İLI4,PC6 and EX3 points for 15 seconds per site,3 days per week for 2 weeks

sham/placebo

Standard hypertension management including prescribed antihypertensive medication and routine clinical nursing follow-up for 2 weeks. No acupressure applied.

control

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18-65 years
  • Diagnosed with primary hypertension (Stage 1 or 2)
  • Systolic blood pressure 130-179 mmHg or diastolic 80-109 mmHg
  • Taking antihypertensive medication
  • Able to understand and communicate in Turkish
  • Willing to provide written informed consent

You may not qualify if:

  • Secondary hypertension
  • Pregnancy or lactation
  • Severe cardiovascular disease (heart failure, myocardial infarction within 6 months)
  • Stroke history within 6 months
  • Skin lesions or infection at acupressure sites (HT7, LI4, PC6, EX3)
  • Peripheral neuropathy affecting sensation
  • Current use of anticoagulant therapy
  • Participation in another clinical trial within 30 days

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

A Family Health Center in Duzce

Düzce, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Essential Hypertension

Condition Hierarchy (Ancestors)

HypertensionVascular DiseasesCardiovascular Diseases

Study Officials

  • Saadet Can Cicek, Associate Professor,PhD

    Abant Izzet Baysal University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Seymanur Ozdemir Arslan, MSc,Phd Candidate

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participants will be randomized into 3 groups:real acupressure, sham acupressure, and usual care
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asst. Prof.Saadet Can Cicek,Phd

Study Record Dates

First Submitted

May 5, 2026

First Posted

May 11, 2026

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

October 1, 2026

Last Updated

May 14, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared to protect participant confidentiality as stated in the informed consent form approved by the ethics committee. Data will only be accessible to the study team for the purposes of this study.

Locations